Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: West | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: West

Contract-Manufactured Products segment sales up 18% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

West
4Q Revenues: $415.6 million (+9%)
4Q Earnings: n/a (earnings were $39.1 million 4Q16)
FY Revenues: $1.6 billion(+6%)
FY Earnings: $150.7 million (+9%)
Comments: Proprietary Products segment sales were up 6% to $306.4 million in the quarter led by double-digit growth in Biologics and high-single digit growth in Generics, offset by a low-single digit decline in Pharma. Contract-Manufactured Products segment sales were up 18% to $109.2 million. During the three and twelve months ended December 31, 2017, the company recorded a tax charge of $48.8 million due to the estimated impact of U.S. tax reform, including the repatriation tax on accumulated foreign earnings.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters